Please login to the form below

Not currently logged in
Email:
Password:

Acquisition

This page shows the latest Acquisition news and features for those working in and with pharma, biotech and healthcare.

Sanofi gains access to antibody tech with Kymab acquisition

Sanofi gains access to antibody tech with Kymab acquisition

The acquisition will also give Sanofi access to new antibody technologies and research capabilities, the company said in a statement. ... The Kymab acquisition is the first acquisition agreed by Sanofi in 2021, following a string of deals made throughout

Latest news

More from news
Approximately 198 fully matching, plus 1,228 partially matching documents found.

Latest Intelligence

  • After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream

    Another example is Biogen’s $800m acquisition of Nightstar’s late-stage gene therapy assets for retinal disease – NSR-REP1 and NSR-RPGR.

  • Rebranding in an evolving world Rebranding in an evolving world

    It goes without saying that partnerships are a fundamental part of that portfolio expansion, which is why another key area of investment has been in mergers and acquisitions. ... We’ve made monumental strides in increasing our European presence through

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    A playing field for acquisitions. One of the world’s leading biotech hubs, Switzerland provides over 50, 000 jobs in the sector and, together with the pharmaceutical and chemical industries, contributes ... And yet the acquisition flow demonstrates

  • AI: the smart money is on the smart thinking AI: the smart money is on the smart thinking

    Recognising this, big pharma firms are already looking to consolidate with AI solutions, if not through acquisitions, then through partnerships. ... Indeed, this has been evidenced recently by Thermo Fisher’s acquisition of Qiagen in May for $11.5bn.

  • Gut instincts lead Takeda to GI pipeline success Gut instincts lead Takeda to GI pipeline success

    Parikh has good reason to celebrate, as he has been involved in constructing a potent GI unit that took its first steps with Takeda’s 2008 acquisition of US biotechnology company ... We are completely focused on helping them.”. The GI building

More from intelligence
Approximately 74 fully matching, plus 92 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 119 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 8 fully matching, plus 73 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...

Infographics